Interest in the structures of dihydrofolate reductases arises for two main reasons. Firstly, it is the smallest nicotinamide nucleotide-dependent dehydrogenase known, and elucidation of its catalytic mechanism may clarify those of the larger dehydrogenases. Table 1 
. Partial sequences (other than dipeptides) from the 'ualine' and 'isoleucine' CNBr fragments
For details see the text. Although most of the data are regarded as sound, some sequences or parts thereof have been found only once. Their confirmed presence in dihydrofolate reductase (and not some minor contaminating protein) must await the full analysis of the CNBr fragments.
Leu-Ala-Gly-Ser-Phe-Glu-Gly-Asp-Thr-Lys-Met-Ile-Pro-Leu-Asn- Secondly, it is the target enzyme for clinically useful folate antagonists, and structural studies offer a deeper understanding of binding properties, and of the phenomenon of resistance, and may lead to the development of more selective inhibitors.
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Materials and methods
We have intermittently studied the sequence of dihydrofolate reductase from methotrexate-resistant Lactobacillus casei as and when pure enzyme, produced for other studies, has been made available. This has limited the scope and efficiency of our sequence strategies, but nevertheless a considerable proportion of the structure has been deduced.
Our study was originally undertaken to complement the X-ray-diffraction work on this enzyme (being carried out in the Astbury Department of Biophysics, University of Leeds), but has also given us an opportunity to develop and assess a novel approach to enzyme sequencing. The data presented here are based on the uses of mass spectrometry as the major sequencing tool, applied in a 'non-specific enzyme strategy' which we have described previously (Morris e f al., 1974) . Several enzymic digests have been studied, and the CNBr fragments isolated, purified and ordered in the sequence.
Results and discussion
During the course of this work, Peterson et al. (1975) and Bennett (1974) reported the sequences of Streptococcus faecium and Escherichia coli dihydrofolate reductases respectively. Their data suggest a considerable degree of homology in the two structures, a particularly well-conserved domain occurring in the N-terminal sequences. The Nterminal 50 residues have been suggested to contain the dihydrofolate-binding site (Peterson et al., 1975) .
We present the N-terminal sequence of Lactobacillus casei dihydrofolate reductase in Fig. 1 . There is striking homology with the E. coli sequence, and particularly with the S. faecium sequence, where 25 of the first 43 residues are identical. The identities between the E. coli and S. faecium sequences also occur in the L. casei enzyme (boxed in Fig. l) , except for residue 41 (Met-42 in the other sequences). This indicates that the methionine residue is not essential for folate binding.
Attention is drawn to the methionine-residue overlap at residue 39. L . casei dihydrofolate reductase contains only two methionine residues, and despite difficulties with the CNBr digest we have succeeded in isolating and purifying the three CNBr fragments in quantities sufficient for amino acid analysis and partial sequence study. Our results indicate a 'threonine fragment' (approx. 39 residues; the N-terminal), a 'valine fragment' (approx. 83 residues) and an 'isoleucine fragment' (approx. 33 residues), and these data agree well with our expected total of approx. 155 residues for the whole protein. Fig. 1 shows the overlap of the first methionine residue into the 'valine fragment', thus positioning the 'isoleucine fragment' in the C-terminus of the molecule. Using our massspectrometric methods we have also obtained a considerable amount of sequence within the 'valine' and 'isoleucine' fragments (Table 1) ; although some can be aligned by homology, overlap data are needed to complete the sequence. The low capacity of nucleotide affinity adsorbents for dehydrogenases is a major consideration in their application to the purification of these enzymes. A survey of the literature shows that, in at least 1 1 cases, less than 1 % of the immobilized ligand used is effective in the retardation of enzymes by such adsorbents (Mosbach et al., 1972; Barry & O'Carrra, 1973; Brodelius & Mosbach, 1973; Brodelius et al., 1974; Harvey et al., 1974; Lowe & Mosbach, 1974; Trayer & Trayer, 1974; Comer et al., 1975; Gestrelius et al., 1975; Hy & Reeves, 1976; Watson & Wootton, 1977) . Thevaluesquoted by these authors are operational capacities and are less than the capacities that were observed when the adsorbent was saturated by either frontal or zonal application. We have measured the capacities of a range of 5'-AMP-, 2'-AMP-and NADP-Sepharose 4B adsorbents for yeast 6-phosphogluconate dehydrogenase by either frontal or zonal saturation and find capacities of the order of 1 % or less. Further, the capacities of each nucleotide immobilized on to Ultrogel AcA22 or the pellicular support Matrex 201R for this enzyme lie in the same range. Similarly, variation of immobilized-ligand concentration in the range O.l-2pmol/ml of settled gel yields comparable capacities. Frontal application allows evaluation of the apparent association constant (Kass,) of the binding process (Nichol etal., 1974) . If this is done in this case, a linear correlation may be drawn between column capacity and association constant for this enzyme applied to a range of Vol. 5
